Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $261.25 USD
Change Today +1.70 / 0.65%
Volume 2.0M
PCYC On Other Exchanges
As of 8:10 PM 05/22/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Joshua T. Brumm

Former Principal Financial Officer, Principal Accounting Officer and Executive Vice President of Finance, Pharmacyclics Inc.
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 3 different industries.

As of Fiscal Year 2013


Mr. Joshua T. Brumm, also known as Josh, has been the Chief Financial Officer of Versartis, Inc. since November 2013. Mr. Brumm served as the Principal Financial Officer and Principal Accounting Officer of Pharmacyclics Inc. since October 25th 2012. Mr. Brumm served as an Executive Vice President of Finance for Pharmacyclics Inc. since August 14, 2012. He served as the Chief Financial Officer at Zeltiq Aesthetics, Inc. from January 1, 2012 to August 8, 2012 and served ...

Read Full Background

Corporate Headquarters*

999 East Arques Avenue
Sunnyvale, California 94085

United States

Phone: 408-774-0330
Fax: 408-774-0340

Board Members Memberships*

There is no Board Members Memberships data available.


University of Notre Dame

Other Affiliations*

Annual Compensation*

Total Annual Compensation$305,000

Stock Options*

Exercisable Options50,457
Unexercisable Options232,637
Total Number of Options283,094

Total Compensation*

Total Annual Cash Compensation$455,000
Total Short Term Compensation$305,000
Total Calculated Compensation$3,388,301
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
PCYC:US $261.25 USD +1.70


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact PHARMACYCLICS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at